Advertisement
The American Journal of Cardiology®
Advanced SearchSave search
Roundtable discussion (CME)| Volume 107, ISSUE 4, P583-590, February 15, 2011

The Editor's Roundtable: Implantable Cardioverter-Defibrillators in Primary Prevention of Sudden Cardiac Death and Disparity-Related Barriers to Implementation

  • Vincent E. Friedewald
    Correspondence
    Corresponding author: Tel: 574-631-6675; fax: 574-631-4505
    Affiliations
    Associate Editor, The American Journal of Cardiology, Clinical Professor, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, and Research Professor, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • Gregg C. Fonarow
    Affiliations
    The Eliot Corday Professor in Cardiovascular Medicine and Science, UCLA Division of Cardiology, University of California, Los Angeles, Los Angeles, California
    Search for articles by this author
  • Brian Olshansky
    Affiliations
    Professor of Medicine, University of Iowa College of Medicine, Iowa City, Iowa
    Search for articles by this author
  • Clyde W. Yancy
    Affiliations
    Medical Director, Baylor Heart and Vascular Institute of Baylor University Medical Center, and Chief, Cardiothoracic Transplantation, Baylor University Medical Center, Dallas, Texas
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute of Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
DOI:https://doi.org/10.1016/j.amjcard.2010.10.003
The Editor's Roundtable: Implantable Cardioverter-Defibrillators in Primary Prevention of Sudden Cardiac Death and Disparity-Related Barriers to Implementation
Previous ArticleRelation of Obesity to Recurrence Rate and Burden of Atrial Fibrillation
Next ArticleComparison of the Effectiveness and Safety of Low-Molecular Weight Heparin Versus Unfractionated Heparin Anticoagulation After Heart Valve Surgery
      This CME activity is supported by an educational grant from Medtronic, Inc. , Minneapolis, Minnesota.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Mirowski M.
        • Reid P.R.
        • Mower M.M.
        • Watkins L.
        • Gott V.L.
        • Schauble J.F.
        • Langer A.
        • Heilman M.S.
        • Kolenik S.A.
        • Frischell R.D.
        • Weisfeldt M.L.
        Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings.
        N Engl J Med. 1980; 303: 322-324
        View in Article
        • Mirowski M.
        • Mower M.M.
        • Langer A.
        • Heilman M.S.
        • Schreibman L.
        A chronically implanted system for automatic defibrillation in active conscious dogs: experimental model for treatment of sudden death from ventricular fibrillation.
        Circulation. 1978; 58: 90-94
        View in Article
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • Estes N.A.M.
        • Freedman R.A.
        • Gettes L.S.
        • Gillinov A.M.
        • Gregoratos G.
        • Hammill S.C.
        • Hayes D.L.
        • Hlatky M.A.
        • Newby L.K.
        • Page R.L.
        • Schonfeld M.H.
        • Sitka M.J.
        • Stevenson L.W.
        • Sweeny M.O.
        ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary.
        Circulation. 2008; 117: 2820-2840
        View in Article
        • Hohnloser S.H.
        • Kuck K.H.
        • Dorian P.
        • Roberts R.S.
        • Hampton J.R.
        • Hatala R.
        • Fain E.
        • Gent M.
        • Connolly S.J.
        • DINAMIT Investigators
        Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
        N Engl J Med. 2004; 351: 2481-2488
        View in Article
        • Fonarow G.C.
        • Yancy C.W.
        • Albert N.M.
        • Curtis A.B.
        • Gattis Stough W.
        • Gheorghiade M.
        • Heywood J.T.
        • Mehra M.
        • O'Connor C.M.
        • Reynolds D.
        • Walsh N.M.
        Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
        Am Heart J. 2007; 154: 12-38
        View in Article
        • Bardy G.H.
        • Lee K.L.
        • Mark D.B.
        • Poole J.E.
        • Packer D.L.
        • Boineau R.
        • Domanski M.
        • Troutman C.
        • Anderson J.
        • Johnson G.
        • McNulty S.E.
        • Clapp-Channing N.
        • Davidson L.D.
        • Fraulo E.S.
        • Fishbein D.P.
        • Luceri R.M.
        • Ip J.H.
        • Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
        Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
        N Engl J Med. 2005; 352: 225-237
        View in Article
        • Hernandez A.F.
        • Fonarow G.C.
        • Liang L.
        • AI-Khatib S.M.
        • Curtis L.H.
        • LaBresh K.A.
        • Yancy C.W.
        • Albert N.M.
        • Peterson E.D.
        Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.
        JAMA. 2007; 298: 1525-1532
        View in Article

      Article Info

      Footnotes

      This discussion took place at Baylor University Medical Center, Dallas, Texas, on October 9, 2008.

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2010.10.003

      Copyright

      © 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX